{
  "_id": "45ffeccbc35a80034c05693090d3e02713efd6f839b4c1e2d3071e05b492ae89",
  "feed": "wall-street-journal",
  "title": "Merck Nears Deal to Acquire Acceleron Pharma; An agreement could be completed as soon as this week, giving a lift to the pharmaceutical giant's work on treatments for rare diseases",
  "text": "<p>Should a deal come together, it would be one of Merck's biggest and represent a bet on the treatments for the respiratory and blood diseases that Acceleron specializes in.</p><p>Acceleron's market value has increased after a sharp rise in the company's shares since last year. The Cambridge, Mass., biotechnology company's stock ran up further on Friday after Bloomberg reported that it was in talks to be acquired by an unnamed buyer.</p><p>Merck has a market value of about $185 billion.</p><p>Jonathan D. Rockoff contributed to this article.</p><p>Write to Cara Lombardo at cara.lombardo@wsj.com and Ben Dummett at ben.dummett@wsj.com</p><p>Merck Nears Deal to Acquire Acceleron Pharma</p>",
  "published": "2021-09-27T21:33:00.000Z",
  "tags": [
    {
      "id": "US58933Y1055",
      "name": "Merck & Co., Inc.",
      "offsets": [
        {
          "start": 48,
          "end": 53
        },
        {
          "start": 430,
          "end": 435
        },
        {
          "start": 0,
          "end": 5
        },
        {
          "start": 614,
          "end": 619
        }
      ],
      "nexusId": "10042334"
    }
  ]
}